- Home
- CHRW vs RVMD Comparison
CHRW vs RVMD Comparison
Compare CHRW & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CHRW | RVMD |
|---|---|---|
| Founded | 1905 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.6B | 15.2B |
| IPO Year | 1997 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CHRW | RVMD |
|---|---|---|
| Price | $164.64 | $80.81 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 20 | 17 |
| Target Price | ★ $147.47 | $77.47 |
| AVG Volume (30 Days) | 1.5M | ★ 2.4M |
| Earning Date | 01-28-2026 | 11-05-2025 |
| Dividend Yield | ★ 1.53% | N/A |
| EPS Growth | ★ 70.68 | N/A |
| EPS | ★ 4.94 | N/A |
| Revenue | ★ $16,504,785,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.97 | $714.50 |
| P/E Ratio | $33.42 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $84.68 | $29.17 |
| 52 Week High | $167.90 | $81.97 |
Technical Indicators
Market Signals| Indicator | CHRW | RVMD |
|---|---|---|
| Relative Strength Index (RSI) | 65.52 | 67.25 |
| Support Level | $163.87 | $74.20 |
| Resistance Level | $167.90 | $81.97 |
| Average True Range (ATR) | 3.57 | 2.50 |
| MACD | 0.09 | -0.44 |
| Stochastic Oscillator | 78.97 | 84.78 |
Price Performance
Historical ComparisonAbout CHRW C.H. Robinson Worldwide Inc.
C.H. Robinson is a top-tier non-asset-based third-party logistics provider with a significant focus on domestic freight brokerage (about 60% of net revenue), which reflects mostly truck brokerage but also rail intermodal. Additionally, the firm operates a large air and ocean forwarding division (30%), which has grown organically and via tuck-in acquisitions over the years. The remainder of revenue consists of transportation management services and a legacy produce-sourcing operation.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.